# XGen Pharmaceuticals DJB, Inc., Horseheads, NY – FDA Inspections

Source: https://www.keypedia.com/companies/xgen-pharmaceuticals-djb-inc/42cd8012-b30d-440e-b2c7-e0d2915c417a

> Inspection records and compliance data for XGen Pharmaceuticals DJB, Inc. in Horseheads, New York. 7 FDA inspections on record, 3 Form 483s, last inspected June 14, 2024.

---

## Details

- Name: XGen Pharmaceuticals DJB, Inc.
- FEI Number: 3005548067
- Business Operations: API/FDF ANALYTICAL TESTING
- Address Line 1: 300 Daniel Zenker Dr
- City: Horseheads
- State: New York
- Zip Code: 14845
- Country Name: United States
- Address: 300 Daniel Zenker Dr, Horseheads, New York 14845, United States
- Country: United States

## Related Documents

- [483 - XGen Pharmaceuticals DJB, Inc. - 2024-07-14](https://www.keypedia.com/records/483/xgen-pharmaceuticals-djb-inc/e382cce9-d874-4e94-9ad2-a26788f57402) — source: FDA, date: July 14, 2024
- [483 - XGen Pharmaceuticals DJB, Inc. - 2024-06-14](https://www.keypedia.com/records/483/xgen-pharmaceuticals-djb-inc/62589896-47b7-4d27-a184-96ef9c6e9dff) — source: FDA, date: June 14, 2024
- [FDA Inspection 1233326 - XGen Pharmaceuticals DJB, Inc. - 2024-06-14](https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/c5cd5149-0c5b-4980-8eb0-631d34b881ff) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2024
- FDA Inspection 1233326 - XGen Pharmaceuticals DJB, Inc. - 2024-06-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2024
- [483 - XGen Pharmaceuticals DJB, Inc. - 2019-08-22](https://www.keypedia.com/records/483/xgen-pharmaceuticals-djb-inc/3e08ac8d-052b-42e4-b0c1-dcb1a49b7848) — source: FDA, date: August 22, 2019
- FDA Inspection 1100288 - XGen Pharmaceuticals DJB, Inc. - 2019-08-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 22, 2019
- [FDA Inspection 1100288 - XGen Pharmaceuticals DJB, Inc. - 2019-08-22](https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/d6b0670c-9dc4-4480-9916-340dd0ac3c7f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 22, 2019
- [FDA Inspection 1056541 - XGen Pharmaceuticals DJB, Inc. - 2018-06-22](https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/b06c3904-011f-45d6-8c89-27ce5387c493) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 22, 2018
- [FDA Inspection 1041478 - XGen Pharmaceuticals DJB, Inc. - 2018-02-16](https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/68e925f6-2144-4752-b80c-f880b2ae982a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 16, 2018
- FDA Inspection 1041478 - XGen Pharmaceuticals DJB, Inc. - 2018-02-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 16, 2018
- [FDA Inspection 954335 - XGen Pharmaceuticals DJB, Inc. - 2015-12-23](https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/fc163fab-7c62-45f1-a5d6-85fe62e38051) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 23, 2015
- FDA Inspection 954335 - XGen Pharmaceuticals DJB, Inc. - 2015-12-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 23, 2015
- FDA Inspection 769993 - XGen Pharmaceuticals DJB, Inc. - 2012-03-08 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 8, 2012

## Related Companies

- [Elyse S. Rafal, M.D.](https://www.keypedia.com/companies/elyse-s-rafal-md/aa8514f3-88d5-4eaf-a609-5b928a2a542c)
- [Sarah D. Atkinson, M.D.](https://www.keypedia.com/companies/sarah-d-atkinson-md/b30a86b0-85c7-4013-80e1-6f71c515cc3a)
- [Mark V. DiBuono, MD](https://www.keypedia.com/companies/mark-v-dibuono-md/d4a83632-9740-40b5-b692-f22b9766a077)
- [AMA Laboratories, Inc.](https://www.keypedia.com/companies/ama-laboratories-inc/413d7c00-6f30-40f7-9a6b-c7097a991cdc)
- [RIJ Pharmaceutical LLC](https://www.keypedia.com/companies/rij-pharmaceutical-llc/80a63e4c-5df4-4e65-9124-341e9b7c39ee)
- [Fayz A. Hudefi, M.D.](https://www.keypedia.com/companies/fayz-a-hudefi-md/01861255-1c5d-4ec4-9bf9-f60e5ecfe54d)
- [Robin Kroll, M.D.](https://www.keypedia.com/companies/robin-kroll-md/22099a0b-4f3b-4078-a5a6-684ae0867507)
- [Antonio E. Blanco, M.D.](https://www.keypedia.com/companies/antonio-e-blanco-md/ef043a91-20ad-4b64-9802-6b8a8c8f937f)
- [GUERBET LLC](https://www.keypedia.com/companies/guerbet-llc/415cb194-2519-4a28-82b2-e5d8846487d0)
- [Ajanta Pharma USA Inc](https://www.keypedia.com/companies/ajanta-pharma-usa-inc/fb94ebd3-ce80-4426-8f91-9f82716e5ea6)

## Related Officers

- [Joanne M. Schlossin](https://www.keypedia.com/people/joanne-m-schlossin/5cb48b8a-d885-4b4f-8c60-d4714d65603d)
- [Investigator ](https://www.keypedia.com/people/karen-l-kosar/6e58be60-f8e3-44f3-8218-8acdde249724)
- [Investigator](https://www.keypedia.com/people/jay-b-shah/c437fff9-807e-4dea-80c0-8f77850db6f8)
- [Kellie B. Kelm](https://www.keypedia.com/people/kellie-b-kelm/df5eaff8-c13d-49e8-b2f6-c3d42a9a7daf)